Birdwatch Archive

Birdwatch Note

2024-10-21 10:57:14 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Dr. Peter Hotez developed a low-cost COVID 19 vaccination called Corbevax whose target demographic was unvaccinated people in poorer countries. https://www.texastribune.org/2022/02/10/corbevax-texas-coronavirus-vaccine/ In 2022, Dr. Hotez was nominated for Nobel Peace Prize. 100 million doses were used in India alone, bypassing Big Pharma. https://www.cidrap.umn.edu/covid-19/who-grants-emergency-listing-corbevax-covid-vaccine

Written by 6D370958E7804FE8153F6917FC30F128E27701D6A56E2F2222741FA1B27FF0BD
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1848251605755232268

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1848317616307491314
  • noteId - 1848317616307491314
  • participantId -
  • noteAuthorParticipantId - 6D370958E7804FE8153F6917FC30F128E27701D6A56E2F2222741FA1B27FF0BD Participant Details
  • createdAtMillis - 1729508234465
  • tweetId - 1848251605755232268
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Dr. Peter Hotez developed a low-cost COVID 19 vaccination called Corbevax whose target demographic was unvaccinated people in poorer countries. https://www.texastribune.org/2022/02/10/corbevax-texas-coronavirus-vaccine/ In 2022, Dr. Hotez was nominated for Nobel Peace Prize. 100 million doses were used in India alone, bypassing Big Pharma. https://www.cidrap.umn.edu/covid-19/who-grants-emergency-listing-corbevax-covid-vaccine

Note Ratings

rated at rated by
2024-10-22 04:50:16 -0500 Rating Details
2024-10-21 14:07:12 -0500 Rating Details
2024-10-21 14:04:15 -0500 Rating Details
2024-10-21 14:03:10 -0500 Rating Details
2024-10-21 13:51:06 -0500 Rating Details
2024-10-21 13:09:23 -0500 Rating Details
2024-10-21 12:48:45 -0500 Rating Details
2024-10-21 09:32:59 -0500 Rating Details
2024-10-21 09:02:26 -0500 Rating Details
2024-10-21 07:30:30 -0500 Rating Details
2024-10-21 15:50:20 -0500 Rating Details
2024-10-21 13:19:50 -0500 Rating Details
2024-10-21 13:04:39 -0500 Rating Details
2024-10-21 12:36:18 -0500 Rating Details
2024-10-21 12:24:37 -0500 Rating Details
2024-10-21 07:39:58 -0500 Rating Details
2024-10-21 06:29:19 -0500 Rating Details
2024-10-22 19:25:21 -0500 Rating Details
2024-10-22 11:38:46 -0500 Rating Details
2024-10-21 19:24:17 -0500 Rating Details
2024-10-21 16:58:16 -0500 Rating Details
2024-10-21 16:44:36 -0500 Rating Details
2024-10-21 12:49:17 -0500 Rating Details
2024-10-21 12:17:31 -0500 Rating Details
2024-10-21 09:49:45 -0500 Rating Details
2024-10-21 08:47:51 -0500 Rating Details
2024-10-21 06:28:19 -0500 Rating Details
2024-10-22 22:19:44 -0500 Rating Details
2024-10-21 22:53:09 -0500 Rating Details
2024-10-21 21:37:33 -0500 Rating Details
2024-10-21 16:59:22 -0500 Rating Details
2024-10-21 15:26:55 -0500 Rating Details
2024-10-21 14:05:30 -0500 Rating Details
2024-10-21 13:39:17 -0500 Rating Details
2024-10-21 13:08:53 -0500 Rating Details
2024-10-21 12:47:57 -0500 Rating Details
2024-10-21 11:50:30 -0500 Rating Details
2024-10-21 11:23:08 -0500 Rating Details
2024-10-21 07:02:34 -0500 Rating Details
2024-10-21 06:33:52 -0500 Rating Details
2024-10-21 06:25:18 -0500 Rating Details
2024-10-21 21:03:57 -0500 Rating Details
2024-10-21 14:30:43 -0500 Rating Details
2024-10-21 13:46:40 -0500 Rating Details
2024-10-21 13:13:32 -0500 Rating Details
2024-10-21 08:38:08 -0500 Rating Details